Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (271-280 of 326) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|August 26, 1998
Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factorJ Gresham, P Margiotta, A J Palad, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 22, 1999
[Frequency of repeated examinations in the ultrasonographic section of a radiological university department]B Krug, H Stützer, K Lackner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethraK H Kurth, P F Schellhammer, E Okajima, et al.
The Journal of Urology|November 13, 2007
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 updateM Craig Hall, Sam S Chang, Guido Dalbagni, et al.
The Prostate|February 15, 1997
Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRPW J Wasilenko, J Cooper, A J Palad, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancerRichard P Ciavarra, Roy R Brown, Daniel A Holterman, et al.
Journal of Endourology|May 4, 2005
Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancerDouglas W Soderdahl, John W Davis, Paul F Schellhammer, et al.
Cancer Research|August 17, 2001
Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate diseaseZ Xiao, B L Adam, L H Cazares, et al.
Urology|August 1, 1996
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapyG L Wright, B M Grob, C Haley, et al.
Urology|August 1, 1995
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study GroupN J Vogelzang, G W Chodak, M S Soloway, et al.
Pageof 33

Showing results (271-280 of 326) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|August 26, 1998
Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factorJ Gresham, P Margiotta, A J Palad, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 22, 1999
[Frequency of repeated examinations in the ultrasonographic section of a radiological university department]B Krug, H Stützer, K Lackner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethraK H Kurth, P F Schellhammer, E Okajima, et al.
The Journal of Urology|November 13, 2007
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 updateM Craig Hall, Sam S Chang, Guido Dalbagni, et al.
The Prostate|February 15, 1997
Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRPW J Wasilenko, J Cooper, A J Palad, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancerRichard P Ciavarra, Roy R Brown, Daniel A Holterman, et al.
Journal of Endourology|May 4, 2005
Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancerDouglas W Soderdahl, John W Davis, Paul F Schellhammer, et al.
Cancer Research|August 17, 2001
Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate diseaseZ Xiao, B L Adam, L H Cazares, et al.
Urology|August 1, 1996
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapyG L Wright, B M Grob, C Haley, et al.
Urology|August 1, 1995
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study GroupN J Vogelzang, G W Chodak, M S Soloway, et al.
Pageof 33